JP2013505251A5 - - Google Patents

Download PDF

Info

Publication number
JP2013505251A5
JP2013505251A5 JP2012529897A JP2012529897A JP2013505251A5 JP 2013505251 A5 JP2013505251 A5 JP 2013505251A5 JP 2012529897 A JP2012529897 A JP 2012529897A JP 2012529897 A JP2012529897 A JP 2012529897A JP 2013505251 A5 JP2013505251 A5 JP 2013505251A5
Authority
JP
Japan
Prior art keywords
implant
kit
different
implant device
sites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012529897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013505251A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/049104 external-priority patent/WO2011035013A2/en
Publication of JP2013505251A publication Critical patent/JP2013505251A/ja
Publication of JP2013505251A5 publication Critical patent/JP2013505251A5/ja
Pending legal-status Critical Current

Links

JP2012529897A 2009-09-17 2010-09-16 放出プロファイルが異なるインプラントデバイス並びにその製造及び使用方法 Pending JP2013505251A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24330309P 2009-09-17 2009-09-17
US61/243,303 2009-09-17
PCT/US2010/049104 WO2011035013A2 (en) 2009-09-17 2010-09-16 Implant devices that differ by release profile and methods of making and using same

Publications (2)

Publication Number Publication Date
JP2013505251A JP2013505251A (ja) 2013-02-14
JP2013505251A5 true JP2013505251A5 (enExample) 2013-11-07

Family

ID=43218276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012529897A Pending JP2013505251A (ja) 2009-09-17 2010-09-16 放出プロファイルが異なるインプラントデバイス並びにその製造及び使用方法

Country Status (10)

Country Link
US (1) US9399018B2 (enExample)
EP (1) EP2477612A2 (enExample)
JP (1) JP2013505251A (enExample)
KR (1) KR20120102598A (enExample)
CN (1) CN102917693B (enExample)
BR (1) BR112012006103B8 (enExample)
CA (1) CA2774495C (enExample)
IN (1) IN2012DN02656A (enExample)
RU (1) RU2012115120A (enExample)
WO (1) WO2011035013A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541028B2 (en) 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US20110091518A1 (en) * 2009-09-22 2011-04-21 Danielle Biggs Implant devices having varying bioactive agent loading configurations
WO2018064556A1 (en) 2016-09-29 2018-04-05 Gesea Biosciences Inc. Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
KR102183669B1 (ko) * 2019-03-26 2020-11-26 가톨릭대학교 산학협력단 이중 약물 방출을 위한 약물 전달체
JP6905035B2 (ja) * 2019-11-29 2021-07-21 Ｎｉｓｓｈａ株式会社 可食性フィルムの製造方法、フィルム製剤及び可食性フィルム

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US4720384A (en) * 1985-05-03 1988-01-19 E. I. Du Pont De Nemours And Company Manufacture of hollow fine tubular drug delivery systems
US4976949A (en) * 1985-10-25 1990-12-11 The University Of Michigan Controlled release dosage form
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
DE3710175A1 (de) * 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
JPS63203610A (ja) * 1987-02-12 1988-08-23 ヘキスト・アクチエンゲゼルシヤフト 複数成分からなるインプラント用の持効性医薬製剤
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
JP2702729B2 (ja) * 1988-02-24 1998-01-26 エーザイ株式会社 徐放性埋込剤
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5178874A (en) * 1989-06-30 1993-01-12 Smithkline Beechman Corporation Intermittent release dosage form
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
JP3118009B2 (ja) 1991-04-16 2000-12-18 住友製薬株式会社 多層構造を有するコラーゲンおよび／またはゼラチン製剤の製造方法
US5876452A (en) * 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
US6013853A (en) * 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
GB9223144D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US6447796B1 (en) * 1994-05-16 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US6855331B2 (en) * 1994-05-16 2005-02-15 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US6902743B1 (en) * 1995-05-22 2005-06-07 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
US5705191A (en) * 1995-08-18 1998-01-06 The United States Of America As Represented By The Secretary Of The Navy Sustained delivery of active compounds from tubules, with rational control
WO1998055101A1 (fr) * 1997-06-04 1998-12-10 Debio Recherche Pharmaceutique S.A. Implants pour la liberation controlee de principes pharmaceutiquement actifs et procede pour leur fabrication
CN1277550A (zh) * 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物
US6296831B1 (en) * 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making
ATE428371T1 (de) * 1998-07-17 2009-05-15 Pacira Pharmaceuticals Inc Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU6326000A (en) 1999-07-26 2001-02-13 Bomac Laboratories Limited Improvements in dispensing vaccines
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
EP1248595A4 (en) * 2000-01-20 2006-06-14 Delsys Pharmaceutical Corp PHARMACEUTICAL FORMS FOR THE STEP BY STEP REDUCTION OF MEDICAMENTS
US6479065B2 (en) * 2000-08-10 2002-11-12 Alkermes Controlled Therapeutics, Inc. Process for the preparation of polymer-based sustained release compositions
US20030055075A1 (en) 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
NZ519363A (en) * 2002-06-05 2004-02-27 Agres Ltd A novel drug dosing regimen
US7101566B2 (en) 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
US7220433B2 (en) * 2003-06-27 2007-05-22 Ethicon, Inc. Compositions for parenteral administration and sustained-release of therapeutic agents
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8685435B2 (en) * 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
WO2005107715A1 (en) 2004-05-11 2005-11-17 Debio Recherche Pharmaceutique S.A. Implantable composition
US8541028B2 (en) * 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US20080254086A1 (en) * 2004-12-23 2008-10-16 Brown James E Controlled Release Compositions
US8969415B2 (en) * 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems

Similar Documents

Publication Publication Date Title
WO2009058990A3 (en) Vascular closure device
BR112012012997A2 (pt) ''microesfera biodegradável, material para utilização em conexão com o tratamento de feridas compreendendo microesferas,curativos de ferida, método para a realização de hemostasia, método para realização do tratamento de uma ferida, método para cultura de células in vitro e método para a realização de embolização vascular"
JP2013505251A5 (enExample)
WO2012034049A3 (en) Implantable medical devices having double walled microspheres
EP3861982A3 (en) Intracameral implant for treatment of an ocular condition
FI3884988T3 (fi) Intravesikaalisesti siedettävä implantoitava laite
IL210024A0 (en) Drug loaded polymeric nanoparticles and methods of making and use using same
BRPI0917390A2 (pt) dispositivo oftálmico tendo capacidade de liberação de agente terapêutico e método de formação do mesmo
EP2644114A3 (en) Layered tissue thickness compensator
CY1119829T1 (el) Βιοαποικοδομησιμες συνθεσεις απελευθερωσης φαρμακου
BRPI0920314A2 (pt) dispositivo médico com liberação controlada de agente antibacteriano
WO2009029958A3 (en) Implantable delivery device
BRPI0920824A2 (pt) dispositivos de liberação prolongada de fármaco com polímeros a base de poliuretano e fabricação dos mesmos
FR2930553B1 (fr) Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases
NZ601200A (en) Pharmaceutical dosage forms comprising poly(epsilon-caprolactone)
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
MX2013012934A (es) Nanoparticulas polimericas para el suministro de farmacos.
WO2010061288A3 (en) Polymeric pharmaceutical dosage form in sustained release
DK2281576T3 (da) Aktiv målsøgende polymermicelle med deri indkapslet medikament samt medicinsk sammensætning
WO2011080141A3 (en) Degradable removable implant for the sustained release of an active compound
NZ604342A (en) Antipsychotic injectable depot composition
WO2014106116A3 (en) Therapeutic compositions comprising antibodies
EP2643009A4 (en) COMPOSITION FOR THE RELEASE OF BIODEGRADABLE ACTIVE SUBSTANCES
EP2349077A4 (en) BIORESORBABLE POLYMERIC COMPOSITIONS AND MEDICAL DEVICES
MX366230B (es) Composiciones multipolimericas para liberación transdermica de farmaco.